Comment on ‘Should Paradoxical Psoriasis Trigger Rheumatological Surveillance During IL-4/IL-13 Blockade?’

Clicks: 11
ID: 322368
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #35 of 178 articles by views in clinical and experimental dermatology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 178 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Lauletta et al. provide important real-world evidence on paradoxical psoriasis and seronegative spondyloarthropathy during IL-4/IL-13 blockade in atopic dermatitis. However, an important unanswered question is whether paradoxical psoriasis represents an early clinical marker of subsequent inflammatory arthritis rather than an isolated adverse event. Clarifying this relationship could inform targeted musculoskeletal surveillance and improve early diagnosis and long-term outcomes.
Reference Key
openalex_W7170719206 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Ercan Yılmaz, Nezihe Koker Özer, E Topal
Journal clinical and experimental dermatology
Year 2026
DOI
10.1093/ced/llag330
URL
https://doi.org/10.1093/ced/llag330
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.